Simonsen et al. evaluated PD-L1 expression in tumor samples from 42 NSCLC patients by IHC and detection of the PD-L1 encoding gene CD274. The results showed that gene-based assessment of PD-L1 expression was also consistent with the initial IHC assessment [48]. The gene discussed is CD274; the disease is neoplasm.